Investigation Of Acorda Therapeutics, Inc. By Securities Lawyers At Goldfarb LLP Law Firm For Potential Shareholder Claim
DALLAS, June 5, 2012 /PRNewswire/ -- Goldfarb LLP is investigating whether the board of directors of Acorda Therapeutics, Inc. (NASDAQ: ACOR) violated shareholder protection laws by allegedly breaching compliance matters concerning adverse drug experience reporting, prompting an investigation by the FDA. Concerned Acorda investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or hlindley@goldfarbllp.com about their rights and remedies.
"If the allegations prove accurate, the company may be subject to extensive penalties for violating U.S. Food and Drug regulations," securities lawyer Hamilton Lindley said. "Our proposed shareholder lawsuit will seek to ensure that strong controls are placed to correct improper behavior and to improve the company's value for investors."
Goldfarb LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. Acorda Therapeutics, Inc. shareholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@goldfarbllp.com or 877-583-2855.
Hamilton Lindley Goldfarb LLP2501 N. Harwood, Ste. 1801 Dallas, TX 75201(877) 583-2855 Toll Free Telephone (214) 583-2233 Local Phone Number (214) 583-2234 Fax Number hlindley@goldfarbllp.com www.goldfarbllp.com
SOURCE Goldfarb LLP
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
